Content by Korea University

|2 min read

Adjuvanted Recombinant COVID-19 Vaccine Outperforms Competitors

The GB510/AS03 vaccine elicits a stronger antibody immune response against the ancestral SARS-CoV-2 strain than ChAdOx1-S
Page 1 of 1